Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib. uri icon

Overview

publication date

  • September 20, 2006

Research

keywords

  • Antineoplastic Agents
  • Carcinoma, Non-Small-Cell Lung
  • Drug Resistance, Neoplasm
  • ErbB Receptors
  • Lung Neoplasms
  • Meningeal Neoplasms
  • Mutation
  • Quinazolines

Identity

Scopus Document Identifier

  • 33749046899

Digital Object Identifier (DOI)

  • 10.1200/JCO.2006.06.6126

PubMed ID

  • 16983123

Additional Document Info

volume

  • 24

issue

  • 27